STING1 and breast cancer: The triple combination increased i.t. CD8+ T cell infiltration, decreased the density of the tumor vasculature, reduced lung metastases, and increased overall survival, which posed a strong rationale for STING therapy and antiangiogenic treatment in BC (127).